Understanding the long-term outcomes is critical for groups who are considering adding these therapies to coverage for weight loss so they can assess whether covering the cost of these therapies for their employees is affordable when long-term adherence and reduction in medical spend has yet to be established. Blue Cross and Blue Shield of Kansas continuously monitors the pharmacy landscape to determine the best course of care for members
Hepatic Dosing There are no defined guidelines for patients with hepatic impairment
As an emollient, it helps trap moisture in the skin
Potential Research Focus Areas (preclinical signals): Soft-Tissue Remodeling: fibroblast activity, ECM deposition, epithelial closure Vascular Support: pro-angiogenic signaling and perfusion metrics Inflammation & Resolution: cytokine balance, pro-resolution mediators Cytoskeletal Dynamics: G-actin interactions and cell motility pathways For Laboratory Research Use Only
Two points of vulnerability First, the gut microbiome can produce TMA from L-carnitine
Davies MJ, Bajaj HS, Broholm C, et al